Home / Inspections / 1156913

FDA Inspection 1156913 — Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. — FEI 1000222037

The FDA completed an inspection of Noven Pharmaceuticals, Inc. on November 17, 2021 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 17, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Facility

Other inspections at this facility

  • 1285900 (NAI Fri Feb 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1040075 (VAI Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934846 (OAI Fri Jul 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 800319 (NAI Mon Sep 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 784597 (NAI Mon Jun 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources